Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Threshold Pharmaceuticals
Threshold Pharmaceuticals
Threshold Pharmaceuticals: TH-302 Phase IIb Clinical Results In First-Line Pancreatic Cancer
Seeking Alpha
Sat, 04/28/12 - 12:43 pm
TH-302
pancreatic cancer
Threshold Pharmaceuticals
Threshold’s cancer drug gets Orphan Drug designation
Proactive Investors
Sat, 03/17/12 - 11:23 am
Threshold Pharmaceuticals
TH-302
sarcoma
The Age Of Personalized Medicine Has Arrived
Seeking Alpha
Thu, 03/8/12 - 10:12 am
personalized medicine
Nektar
Life Technologies
Threshold Pharmaceuticals
Threshold Scores Big With Pancreatic Cancer Data
Seeking Alpha
Mon, 03/5/12 - 11:08 am
pancreatic cancer
Threshold Pharmaceuticals
TH-302
Amgen
Array Biopharma
Micromet
Merck
Pharmacyclics
Threshold Pharmaceuticals: Understanding The Recent Data
Seeking Alpha
Wed, 02/29/12 - 11:07 am
Threshold Pharmaceuticals
TH-302
pancreatic cancer
Not Just Any Biotech Stock Will Do
Motley Fool
Sat, 02/25/12 - 09:20 am
PDL Biopharma
Amgen
Threshold Pharmaceuticals
Threshold Pharma's TH-302 for pancreatic cancer shows positive Phase 2b results
Yahoo/Fly on the Wall
Tue, 02/21/12 - 09:02 am
Threshold Pharmaceuticals
pancreatic cancer
TH-302
Threshold Pharmaceuticals: Up 150% In 4 Months With Room To Grow
Seeking Alpha
Tue, 02/7/12 - 04:41 pm
Threshold Pharmaceuticals
TH-302
hypoxia
pancreatic cancer
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
BioMedReports
Sat, 02/4/12 - 05:01 pm
Threshold Pharmaceuticals
Merck KGaA
TH-302
sarcoma
pancreatic cancer
FDA Pending Catalysts For 5 Biotechs
Seeking Alpha
Wed, 01/25/12 - 10:51 am
FDA
Amylin
NeurogesX
Threshold Pharmaceuticals
Astex
Cell Therapeutics
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
Threshold Pharma announces clinical trial results of Phase 1 TH-302 study
Yahoo/Fly on the Wall
Wed, 12/14/11 - 11:18 am
Threshold Pharmaceuticals
leukemia
TH-302
9 Biotech Stocks Being Snapped Up By Company Insiders
Seeking Alpha
Sun, 11/6/11 - 12:06 pm
Complete Genomics
Theravance
Ziopharm
Threshold Pharmaceuticals
Repros Therapeutics
MannKind
PharmAthene
Seattle Genetics
Corcept Therapeutics
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Seeking Alpha
Tue, 10/25/11 - 10:49 am
pancreatic cancer
Amgen
Celgene
Infinity
Oncolytics
Pharmacyclics
Immunomedics
Threshold Pharmaceuticals
Clovis Oncology
Novartis
Aduro BioTech
NewLink Genetics
Seattle Genetics
Bayer Schering
Astellas
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Seeking Alpha
Sat, 10/8/11 - 11:46 am
ThermoDox
Celsion
liver cancer
Threshold Pharmaceuticals
TH-302
leukemia
Medivation
dimebon
Alzheimer's disease
MDV3100
prostate cancer
Pfizer
12 Cancer Stocks Being Snapped Up by Insiders
Seeking Alpha
Fri, 08/19/11 - 12:09 pm
OPKO Health
Tengion
GTx
Anadys
Complete Genomics
Amag Pharmaceuticals
MannKind
Threshold Pharmaceuticals
Synta
Genomic Health
Ziopharm
Ardea
More Hot Biotech Trades for Second Half 2011
TheStreet.com
Tue, 07/12/11 - 10:27 am
Targacept
Aveo Pharmaceutical
Threshold Pharmaceuticals
Raptor Pharmaceuticals
Vertex Pharmaceuticals
Soligenix
Spectrum Pharmaceuticals
NuPathe
Pharmasset
Incyte
Adventrx
Celsion
Alimera
GTx
Ariad Pharmaceuticals
Low-Priced Biotech Stocks With Insider Buying
Seeking Alpha
Sat, 03/19/11 - 10:06 am
Ligand
Dyax
Bioclinica
Synta Pharmaceuticals
Threshold Pharmaceuticals
Chelsea Therapeutics
Alimera
Cerus
Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
Seeking Alpha
Thu, 02/17/11 - 01:02 pm
Apricus Biosciences
liver cancer
ProvOnco
Threshold Pharmaceuticals
Threshold Pharmaceuticals Presents Encouraging Data From Clinical Trials of TH-302 for Solid Tumors
Yahoo
Sat, 05/30/09 - 10:03 am
Threshold Pharmaceuticals
Pages
« first
‹ previous
1
2
3